Skip to main content
. 2021 Feb 9;11(2):e044054. doi: 10.1136/bmjopen-2020-044054

Table 1.

Health utility estimates from EQ-5D-5L data collected during the ORBITA trial; higher scores indicate better health

Utility weight
Health state Number Mean SE SD
CAD (baseline) 195 0.77 0.015 0.213
Placebo 91 0.81 0.021 0.221
PCI 104 0.83 0.023 0.212

Number =the number of patients in the sample, with a complete EQ-5D utility weight, used to estimate the mean, SE and SD.

CAD, coronary artery disease; EQ-5D-5L, EuroQol five-dimension quality of life instrument, 5-level version; ORBITA trial, Objective Randomised Blinded Investigation with optimal medical Therapy of Angioplasty in stable angina trial; PCI, percutaneous coronary intervention; SD, Standard deviation; SE, Standard error.